NCT06141265
- Conditions
- Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Explore clinical trials studying Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma trial results
Active, Not Recruiting
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
NCT03602859
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- GSK Investigational Site Anchorage, Alaska, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States